Sensei Biotherapeutics Inc
F:407
Sensei Biotherapeutics Inc
F:407
Price:
5.2
EUR
Market Closed
Market Cap:
€138.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sensei Biotherapeutics Inc
F:407
|
US |
|
Everspin Technologies Inc
NASDAQ:MRAM
|
US |
|
Centrotherm International AG
F:CTNK
|
DE |
|
HomeStreet Inc
NASDAQ:HMST
|
US |
|
2
|
2G Energy AG
XETRA:2GB
|
DE |
|
N
|
NextBioMedical Co Ltd
KOSDAQ:389650
|
KR |
|
Dlsi SA
PAR:ALDLS
|
FR |
|
P
|
Primoris Services Corp
NYSE:PRIM
|
US |
|
D
|
DS Dansuk Co Ltd
KRX:017860
|
KR |
|
E
|
Ege Profil Ticaret ve Sanayi AS
IST:EGPRO.E
|
TR |
|
Hawaiian Holdings Inc
NASDAQ:HA
|
US |
|
G
|
Graubuendner Kantonalbank
SIX:GRKP
|
CH |
|
Navarre Minerals Ltd
ASX:NML
|
AU |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of Sensei Biotherapeutics Inc.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
Competitors Multiples
Sensei Biotherapeutics Inc Competitors
Sensei Biotherapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Sensei Biotherapeutics Inc
F:407
|
40m EUR | 0 | -1.9 | -0.8 | -0.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD | 6.1 | 89.7 | 14.9 | 20.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.2 | 24.9 | 14.4 | 14.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD | 6 | 20.8 | 12.9 | 16 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.7 | 21.6 | 22.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18 | 13.5 | 15.4 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR | 11.8 | 37.9 | 40.9 | 41.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3 | 33.2 | 11.2 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
